Clinical Trials
4 trialsNCT02009449 2024-11-15
IVY
Eli Lilly and Company
Phase 1 Completed
NCT03382899 2021-01-20
Cypress 1
Eli Lilly and Company
Phase 2 Terminated
NCT03382912 2020-09-11
Cypress 2
Eli Lilly and Company
Phase 2 Terminated
NCT03554434 2020-03-02
An Expanded Access Program for AM0010 (Pegilodecakin)
Eli Lilly and Company
No longer available